Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implantMoazzam Ali, David Hubacher, Ayşe Akın et al.|Human Reproduction|2016Cited by 127
A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placementLuís Bahamondes, Ndema Habib, Vivian Brache et al.|Contraception|2018Cited by 34
A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mgMario Festin, Nathalie Kapp, Luís Bahamondes et al.|Human Reproduction|2016Cited by 28
Impact of COVID-19 pandemic on family planning and sexual transmitted infection services in Thailand: results from WHO surveyJen Sothornwit, Massimo Mirandola, Rachel Esteves Soeiro et al.|Reproductive Health|2025Cited by 3
Evidence on sexual and reproductive health service delivery during and post COVID-19: a multi-country facility assessmentMoazzam Ali, Stefano Uccella, Grace Kapustianyk et al.|Reproductive Health|2025Cited by 2